News and Trends 28 Nov 2022 Biomemory raises €5M to advance DNA digital data storage solution …DNA synthesis and copy process based on synthetic biology, exploiting mechanisms refined over four billion years of evolution. Applying proprietary technologies, Biomemory can produce long, bio-sourced, biocompatible and bio-secure DNA… November 28, 2022 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 6 Aug 2021 Artios’ €129M Series C Pushes Limits of DNA Repair in Cancer The UK firm Artios Pharma raised a huge Series C round last week in one of many efforts to develop cancer drugs that target the DNA repair systems of our… August 6, 2021 - 4 minutesmins - By Anita Chakraverty Share WhatsApp Twitter Linkedin Email
In Depth 29 Sep 2023 Illumina: DNA giant in troubled waters …cough up $476 million to pay off a record fine. The call for divestment comes after a long-drawn-out antitrust case that has weighed down the DNA giant for a while… September 29, 2023 - 8 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 23 Apr 2019 Combining DNA and RNA Testing Could Improve Precision Medicine for Cancer …far only some cancer sufferers can benefit from these therapies. Most precision medicine studies determine the best treatment based on mutations in tumor DNA, but not all tumors carry… April 23, 2019 - 3 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 27 Nov 2017 You Can Now Play DNA Tetris Thanks to This Irish Startup How cool would it be to program DNA at home to make gifs or play Tetris? Well, this device will soon let you do just that. Cell-Free Technologies wants to… November 27, 2017 - 3 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
Startup Scout 2 Nov 2022 Breakpoint Therapeutics sabotages DNA repair in cancer cells …DNA. In the case of tumor cells that are already impaired with mutations in their DNA repair machinery, this strategy can quickly kill the tumor. However, current DDR drugs can… November 2, 2022 - 4 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 28 Nov 2017 Cheap DNA Tests for Everyone! Italian Biotech Launches €149 Kit …a number of biotechs in this area, including DNAlytics’ test for arthritic diseases and Ampligen’s HPV test for uterine cancer. DNA testing technology is now becoming more and more accessible… November 28, 2017 - 3 minutesmins - By Alex Dale Share WhatsApp Twitter Linkedin Email
Best in Biotech 18 Jul 2017 Is DNA the Future? The Best Biotech Talks of the Year …development of recombinant DNA technology to the current state of the field. With DNA sequencing and synthesis costs lower than ever, Berry thinks our ability to control genes precisely will… July 18, 2017 - 3 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 20 Mar 2018 DNA Sequencing Unicorn Oxford Nanopore Raises £100M Round at £1.5Bn Valuation …DNA in real time with high accuracy. As DNA passes through the nanopore, it causes changes in current which can be detected and used to sequence the DNA. Oxford Nanopore… March 20, 2018 - 2 minutesmins - By Alexander Burik Share WhatsApp Twitter Linkedin Email
News and Trends 5 Oct 2016 €365M deal for a Danish ‘DNA barcode’ Drug Screening Platform …of big Pharma? Nuevolution’s high-throughput drug discovery platform, Chemetics, uses DNA barcodes to identify every molecule. The candidates that bind best to the desired target can then be quickly identified… October 5, 2016 - 3 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 2 Nov 2022 Could DNA nanotransporters treat cancer? A team of Canadian researchers from Université de Montréal has designed and validated a new class of drug transporters made of DNA 20,000 times smaller than a human hair. The… November 2, 2022 - 4 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 25 Jul 2022 Replay launches with $55M to reprogram biology by writing and delivering big DNA Replay, a genome writing company reprogramming biology by writing and delivering big DNA, has launched with $55 million in seed financing. The round was led by KKR and OMX Ventures,… July 25, 2022 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email